ClinicalTrials.govpublic full text
Sorafenib and Docetaxel in Patients With Prostate Cancer That Did Not Respond to Previous Hormone Therapy
prostate cancer, adenocarcinoma of the prostate, recurrent prostate cancer, stage iv prostate cancer, interventional, phase2
This document is indexed with metadata only — full text is not available in the archive for this record.
Open the official source ↗
Related documents
Record · ID 865620
Retrieved via
Conceptio — every document is proof-bundled with source, license, and retrieval metadata.